A critical breakthrough in cancer study is emerging with the use of VHH fragments to restore damaged p53. This vital malignant inhibitor protein is frequently disabled in several types of tumors, resulting uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research